Core Viewpoint - The Ultragenyx Pharmaceutical Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the efficacy of their drug setrusumab during clinical trials [1][3]. Group 1: Class Action Details - The class action lawsuit is titled Bailey v. Ultragenyx Pharmaceutical Inc., and it involves purchasers of Ultragenyx common stock from August 3, 2023, to December 26, 2025 [1]. - Investors have until April 6, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Ultragenyx misrepresented the reliability of information regarding the effects of setrusumab on Osteogenesis Imperfecta patients and downplayed the risks associated with the Phase III Orbit study [3]. Group 2: Allegations and Stock Impact - On July 9, 2025, Ultragenyx disclosed that the Phase III Orbit study did not achieve statistical significance for its second interim analysis, leading to a stock price drop of over 25% [4]. - Following a December 29, 2025 announcement that both the Phase III Orbit and Cosmic studies failed to meet primary endpoints, Ultragenyx's stock fell more than 42% [5]. - The company attributed the study failures to a low fracture rate in the placebo group and a trend that did not reach statistical significance [5]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Ultragenyx stock during the class period to seek lead plaintiff status, representing the interests of the class [6]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized as a leading firm in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [7].

Core Viewpoint - PayPal Holdings, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential during the Class Period from February 25, 2025, to February 2, 2026 [1] Summary by Sections Class Action Lawsuit Details - The lawsuit, Goodman v. PayPal Holdings, Inc., claims that PayPal and certain executives violated the Securities Exchange Act of 1934 [1] - Investors who suffered substantial losses during the Class Period have until April 20, 2026, to seek appointment as lead plaintiff [1] Allegations Against PayPal - The lawsuit alleges that PayPal created a false impression of having reliable information about its projected revenue and growth while downplaying risks from seasonality and macroeconomic factors [1] - PayPal's growth initiatives, particularly in Branded Checkout, were deemed unrealistic and not achievable under CEO James Alexander Chriss [1] - On February 3, 2026, PayPal reported disappointing earnings for Q4 and full fiscal year 2025, withdrawing its 2027 financial targets, which led to a stock price drop of over 20% [1] Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal common stock during the Class Period to seek lead plaintiff status [1] - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [1] About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 [1] - The firm has a strong track record, recovering $8.4 billion for investors over the past five years [1]

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) for allegedly misleading investors about tenant demand and funding for its Project Matador AI campus during the Class Period from October 1, 2025, to December 11, 2025 [1]. Company Overview - Fermi Inc. is headquartered in Amarillo, Texas, and aims to establish a network of large, grid-independent data centers powered by nuclear, natural gas, solar, and battery energy [1]. Legal Allegations - The lawsuit claims that during the Class Period, Fermi's management misled investors regarding the demand for Project Matador AI and the project's funding status [1]. - It is alleged that the construction financing for Project Matador was reliant on a single tenant's funding commitment, which posed a significant risk of withdrawal [1]. - The complaint asserts that public statements made by the defendants lacked a reasonable basis due to these concealed risks [1].

Core Viewpoint - NuScale Power Corporation is facing a class action lawsuit due to alleged misleading statements regarding its commercialization partnership with ENTRA1 Energy LLC and the financial implications of its operations [1][3]. Company Overview - NuScale Power Corporation specializes in small modular nuclear reactors, specifically the NuScale Power Module (NPM), aimed at generating energy within larger power plants [2]. - The company entered a global commercialization partnership with ENTRA1 Energy LLC, which was expected to advance its NPM technology from development to deployment [2]. Allegations of the Lawsuit - The lawsuit claims that NuScale and its executives made false statements about ENTRA1's capabilities, failing to disclose that ENTRA1 had no significant experience in building or operating nuclear power projects [3]. - It is alleged that NuScale's reliance on ENTRA1 exposed the company to undisclosed risks related to commercialization, distribution, and deployment of its NPMs [3]. Financial Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses, which surged over 3,000% to $519 million from $17 million in the previous year, primarily due to a $495 million payment to ENTRA1 [4]. - The company's quarterly net loss escalated to $532 million, up from $46 million in the prior year, following the announcement of the TVA agreement [4]. - Following the financial disclosures, NuScale's Class A shares dropped more than 12% over a two-day trading period [4]. Legal Process - Investors who purchased NuScale Class A common stock during the specified class period can seek appointment as lead plaintiff in the class action lawsuit [6]. - The lead plaintiff will represent the interests of all class members and can select a law firm for litigation [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is representing the plaintiffs and is recognized as a leading firm in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [7].

Company Overview - Oddity Tech Ltd. operates as a consumer technology company focused on building digital-first brands in the beauty and wellness industries [3] Financial Results and Issues - On February 25, 2026, Oddity reported its full year 2025 financial results, indicating a significant dislocation in its account with its largest advertising partner due to algorithm changes. This led to a diversion to lower quality auctions at abnormally high costs, resulting in increased new user acquisition costs that are not aligned with market trends or historical performance [4] Stock Performance - Following the financial disclosure, Oddity's stock price experienced a dramatic decline of over 49% [4] Legal Investigation - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Oddity Tech Ltd. [1]

New York, New York--(Newsfile Corp. - March 2, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ: PLUG) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Plug Power, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/plug-power-cla ...

Core Viewpoint - Hub Group Inc. is under investigation for potential violations of federal securities laws, specifically regarding misrepresentation of transportation costs and accounts payable for the first nine months of 2025 [2]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Hub Group for possible misrepresentation of financial data [1][2]. - The investigation focuses on whether Hub Group inaccurately reported its purchased transportation costs and accounts payable [2]. Group 2: Stock Performance - Hub Group announced a delay in the release of its fourth quarter and full year 2025 financial results, along with a restatement of its financial statements for the first three quarters of 2025 due to an error in reporting transportation costs and accounts payable [3]. - Following this announcement, Hub Group's stock price fell over 24% during trading on February 6, 2026 [4].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its accounts receivable collection practices, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method for reserving accounts [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [5][10].

Core Viewpoint - Eos Energy Enterprises, Inc. is under investigation for potential violations of federal securities laws, particularly concerning misleading statements about revenue growth and manufacturing reliability [1][3]. Group 1: Company Overview - Eos manufactures zinc-based long-duration battery energy storage systems aimed at storing renewable energy and enhancing grid reliability [2]. Group 2: Investigation Details - The investigation focuses on whether Eos made false and misleading statements regarding its near-term revenue growth and the execution of its manufacturing efforts [3][10]. - The investigation was prompted by Eos's significant net loss of approximately $970 million for fiscal year 2025 and a revenue forecast that fell short of previously stated guidance [4]. Group 3: Financial Performance - Eos reported a net loss of about $970 million for fiscal year 2025, attributing this to high spending on manufacturing scale-up, inefficiencies, and non-cash charges [4]. - The company issued weaker-than-expected revenue guidance for 2026, citing slower production progress and increased execution risk [4]. Group 4: Stock Market Reaction - Following the announcement of its financial results, Eos's stock price dropped over 39% on February 26, 2026 [5][10].

Group 1 - The investigation into GRAIL, Inc. by Levi & Korsinsky focuses on potential violations of federal securities laws [1] - GRAIL, Inc. updated its cash-burn guidance to no more than $290 million for the full year of 2025, indicating a significant financial outlook [2] - The company believes its cash runway extends into 2030, which is expected to support major clinical and regulatory milestones, including the FDA PMA submission and results from the NHS Galleri study [2] Group 2 - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]